A functional interferon regulatory factor-1 (IRF-1)-binding site in the upstream regulatory region (URR) of human papillomavirus type 16

被引:14
作者
Arany, I
Grattendick, KJ
Whitehead, WE
Ember, IA
Tyring, SK
机构
[1] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA
[2] Univ Texas, Med Branch, Dept Microbiol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Dept Immunol, Galveston, TX 77555 USA
[4] Univ Pecs, Sch Med, Dept Prevent Med & Public Hlth, H-7643 Pecs, Hungary
[5] Univ Texas, Med Branch, Dept Dermatol, Galveston, TX 77555 USA
关键词
HPV16; transcription; promoter; enhancer; interferon; IRF-1; IRF-E;
D O I
10.1016/S0042-6822(03)00138-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently identified a new enhancer element (HIRE-1, HPV-Interferon Responsive Element-1) in the upstream regulatory region (URR) of human papillomavirus (HPV) type 16. HIRE-1 is located upstream from and in close proximity to the TATA box. HIRE-1 is 1 nt shorter in its 5' sequence in comparison to a consensus IRF-1 binding site (IRF-E). Gel shift analyses clearly demonstrated that HIRE-1 is capable of binding IRF-1 in response to interferon-gamma (IFN-gamma) treatment. In a reporter system, HIRE-1 stimulated transcription in response to IRF-1 or IFNgamma from both a heterologous or the homologous (p97) promoter in a dose-dependent manner. Mutations in the core binding sequence strongly decreased this enhancer activity. Interestingly, HIRE-1 stimulated transcription in the context of the full URR in a cell-type-specific manner, thereby suggesting the role of other cell-type-specific factors that might counteract with its function. Thus, our results may explain the inconsistent clinical and experimental results observed following IFN treatment of cervical lesions or cells. Also, this new enhancer may have an important function during inflammatory responses against HPV type 16. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 30 条
[1]   Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR) [J].
Arany, I ;
Grattendick, KG ;
Tyring, SK .
ANTIVIRAL RESEARCH, 2002, 55 (02) :331-339
[2]   Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells [J].
Arany, I ;
Whitehead, WE ;
Grattendick, KJ ;
Ember, IA ;
Tyring, SK .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (05) :1102-1106
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   Establishment and characterization of a human-papillomavirus negative, p53-mutation negative human cervical cancer cell line [J].
Chou, CY ;
Chen, YH ;
Tzeng, CC ;
Cheng, YC ;
Chang, CF ;
Chen, TM .
CANCER LETTERS, 1996, 102 (1-2) :173-181
[5]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[6]   GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression [J].
Decker, T ;
Kovarik, P ;
Meinke, A .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (03) :121-134
[7]  
DEMARCO F, 1991, J BIOL REG HOMEOS AG, V5, P65
[8]   Control of papillomavirus DNA replication and transcription [J].
Desaintes, C ;
Demeret, C .
SEMINARS IN CANCER BIOLOGY, 1996, 7 (06) :339-347
[9]  
Gaiotti D, 2000, MOL CARCINOGEN, V27, P97, DOI 10.1002/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO
[10]  
2-V